Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?

Rolf L, Muris AH, Theunissen R, Hupperts R, Damoiseaux J, Smolders J.

J Neuroimmunol. 2018 Jan 15;314:50-57. doi: 10.1016/j.jneuroim.2017.11.007. Epub 2017 Nov 10.

PMID:
29153546
2.

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R.

Mult Scler. 2018 Sep;24(10):1280-1287. doi: 10.1177/1352458517722646. Epub 2017 Jul 21.

3.

Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression.

Rolf L, Muris AH, Bol Y, Damoiseaux J, Smolders J, Hupperts R.

J Neurol Sci. 2017 Jul 15;378:30-35. doi: 10.1016/j.jns.2017.04.017. Epub 2017 Apr 19.

PMID:
28566173
4.

Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study.

Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J; SOLARIUM study group.

J Neuroimmunol. 2016 Nov 15;300:47-56. doi: 10.1016/j.jneuroim.2016.09.018. Epub 2016 Oct 3.

PMID:
27806875
5.

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.

Muris AH, Smolders J, Rolf L, Klinkenberg LJ, van der Linden N, Meex S, Damoiseaux J, Hupperts R.

PLoS One. 2016 Jun 8;11(6):e0156122. doi: 10.1371/journal.pone.0156122. eCollection 2016.

6.

Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.

Smolders J, Muris AH, Damoiseaux J.

J Neuroimmunol. 2016 Mar 15;292:79-80. doi: 10.1016/j.jneuroim.2016.01.017. Epub 2016 Jan 27. No abstract available.

PMID:
26943962
7.

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

Rolf L, Muris AH, Hupperts R, Damoiseaux J.

Immunology. 2016 Mar;147(3):275-84. doi: 10.1111/imm.12572. Epub 2016 Feb 2. Review.

8.

A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.

Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J.

J Steroid Biochem Mol Biol. 2016 Nov;164:254-257. doi: 10.1016/j.jsbmb.2015.11.009. Epub 2015 Nov 17. Review.

PMID:
26598277
9.

GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.

Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M.

J Neuroimmunol. 2015 Mar 15;280:36-42. doi: 10.1016/j.jneuroim.2015.02.007. Epub 2015 Feb 26.

PMID:
25773153
10.

Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis.

Peelen E, Damoiseaux J, Muris AH, Knippenberg S, Smolders J, Hupperts R, Thewissen M.

Mol Immunol. 2015 Feb;63(2):521-9.

PMID:
25458313
11.

Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.

Muris AH, Rolf L, Damoiseaux J, Koeman E, Hupperts R.

BMC Neurol. 2014 Aug 20;14:164. doi: 10.1186/s12883-014-0164-5.

12.

Vitamin D effects on B cell function in autoimmunity.

Rolf L, Muris AH, Hupperts R, Damoiseaux J.

Ann N Y Acad Sci. 2014 May;1317:84-91. doi: 10.1111/nyas.12440. Epub 2014 Apr 24. Review.

PMID:
24761763
13.

Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.

Rolf L, Muris AH, Damoiseaux J, van Daele M, Hupperts R.

Neurology. 2014 Mar 18;82(11):1008-9. doi: 10.1212/WNL.0000000000000218. Epub 2014 Feb 12. No abstract available.

PMID:
24523479
14.

Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.

Peelen E, Thewissen M, Knippenberg S, Smolders J, Muris AH, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

J Neuroimmunol. 2013 May 15;258(1-2):77-84. doi: 10.1016/j.jneuroim.2013.02.014. Epub 2013 Mar 19.

15.

Comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'.

Muris AH, Smolders J, Damoiseaux J.

Mult Scler. 2013 Apr;19(4):510. doi: 10.1177/1352458512457846. Epub 2012 Aug 20. No abstract available.

PMID:
22907942
16.

Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.

Muris AH, Damoiseaux J, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M.

J Immunol Methods. 2012 Jul 31;381(1-2):59-65. doi: 10.1016/j.jim.2012.04.011. Epub 2012 Apr 29.

PMID:
22565155
17.

Effects of vitamin D on the peripheral adaptive immune system: a review.

Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2011 Oct;10(12):733-43. doi: 10.1016/j.autrev.2011.05.002. Epub 2011 May 18. Review.

PMID:
21621002
18.

Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.

Vrolix K, Niks EH, Le Panse R, van Ostaijen-Ten Dam MM, Muris AH, Jol-van der Zijde CM, van Tol MJ, Losen M, Molenaar PC, van Zoelen EJ, Berrih-Aknin S, De Baets MH, Verschuuren JJ, Martínez-Martínez P.

J Neuroimmunol. 2011 Mar;232(1-2):158-65. doi: 10.1016/j.jneuroim.2010.10.024. Epub 2010 Dec 18.

PMID:
21168922

Supplemental Content

Loading ...
Support Center